Pharmaceutical giant Johnson & Johnson and Biomedical Advanced Research and Development Authority (BARDA) together committed more than $1 billion to novel coronavirus vaccine research and development. It is being developed by Janssen Vaccines & Prevention in Leiden,a subsidiary of American pharmaceutical company, Johnson & Johnson.
Alex Gorsky, Chairman, and Chief Executive Officer, Johnson & Johnson, said,